The Market Reports

Synopsis
The global market for Blood Irradiation was estimated to be worth US$ 95.6 million in 2024 and is forecast to a readjusted size of US$ 125 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Irradiation of human blood is used to avoid the TA-GVHD (transfusion-associated graft-versus-host-disease), a rare but devastating adverse effect of leukocytes present in blood component for immunocompetent transfusion recipients. It is worth noting that cesium and X-ray irradiators are devices dedicated to blood irradiation, usually operated by specialized institutions or departments external to the healthcare facilities that are actually using the irradiated blood (and thus have to purchase it from the irradiation service providers); in contrast, many user facilities already have LINACs and cobalt sources for cancer therapy and other treatments. These units, although they are designed for other purposes, can be used for blood irradiation on a limited basis. For example, a blood bag holder can be placed where a patient would be exposed and the LINAC operated to irradiate the blood instead of a person.
The primary drivers of the blood irradiation market is the rising prevalence of immune-compromised conditions, such as cancer, organ transplant, and autoimmune diseases. These conditions often require blood transfusions, where blood irradiation can prevent transfusion-associated graft-versus-host disease (TA-GVHD). Additionally, advancements in blood irradiation technology and increased healthcare spending globally are boosting market demand. Regulatory agencies in many regions have also established strict guidelines to ensure the safety of blood transfusions, promoting the adoption of blood irradiation equipment in hospitals and blood banks.
A significant challenge for the blood irradiation market is the high cost associated with irradiation equipment and maintenance. These expenses can be prohibitive for smaller healthcare facilities and blood banks, limiting adoption in low-resource settings. Another challenge is the growing availability of alternative methods for blood sterilization and immunomodulation, which compete with blood irradiation. Regulatory barriers and the need for extensive training and specialized staff for handling irradiation equipment further add to the cost and operational complexity, impacting market growth, particularly in developing countries.
Global Blood Irradiation key players include Best Theratronics, Fujifilm, Gilardoni, Gamma-Service, etc. Global top four manufacturers hold a share about 70%. North America is the largest market, with a share over 35%, followed by Europe, and Japan, both have a share about 40 percent. In terms of product, Gamma-ray Blood Irradiation is the largest segment, with a share over 50%. And in terms of application, the largest application is Blood Bank, followed by Hospital, Research Institutions.
This report aims to provide a comprehensive presentation of the global market for Blood Irradiation, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blood Irradiation by region & country, by Type, and by Application.
The Blood Irradiation market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Irradiation.
Market Segmentation
By Company
Best Theratronics
Fujifilm
Gilardoni
Eckert & Ziegler
Actemium
WEGO (Rad Source)
Shinva Medical
LIVZON
Segment by Type
X-ray Blood Irradiation
Gamma-ray Blood Irradiation
Segment by Application
Blood Bank
Hospital
Research Institutions
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Irradiation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Blood Irradiation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Blood Irradiation in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index